{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:34:37Z","timestamp":1775698477475,"version":"3.50.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurosci"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/nrn2168","type":"journal-article","created":{"date-parts":[[2007,6,6]],"date-time":"2007-06-06T06:40:22Z","timestamp":1181112022000},"page":"499-509","source":"Crossref","is-referenced-by-count":1669,"title":["Intracellular amyloid-\u03b2 in Alzheimer's disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Frank M.","family":"LaFerla","sequence":"first","affiliation":[]},{"given":"Kim N.","family":"Green","sequence":"additional","affiliation":[]},{"given":"Salvatore","family":"Oddo","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BFnrn2168_CR1","first-page":"146","volume-title":"Allgemeine Zeitschrift f\u00fcr Psychiatrie und Psychisch-Gerichtliche Medizine","author":"A Alzheimer","year":"1907","unstructured":"Alzheimer A. \u00dcber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift f\u00fcr Psychiatrie und Psychisch-Gerichtliche Medizine 64, 146\u2013148 (1907)."},{"key":"BFnrn2168_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner, G. G. & Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885\u2013890 (1984).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrn2168_CR3","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245\u20134249 (1985).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR4","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1073\/pnas.85.11.4051","volume":"85","author":"M Goedert","year":"1988","unstructured":"Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E. & Klug, A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl Acad. Sci. USA 85, 4051\u20134055 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR5","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","volume":"83","author":"I Grundke-Iqbal","year":"1986","unstructured":"Grundke-Iqbal, I. et al. Abnormal phosphorylation of the microtubule-associated protein \u03c4 (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 4913\u20134917 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/oxfordjournals.jbchem.a135662","volume":"99","author":"Y Ihara","year":"1986","unstructured":"Ihara, Y., Nukina, N., Miura, R. & Ogawara, M. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. J. Biochem. (Tokyo) 99, 1807\u20131810 (1986).","journal-title":"J. Biochem. (Tokyo)"},{"key":"BFnrn2168_CR7","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","volume":"83","author":"KS Kosik","year":"1986","unstructured":"Kosik, K. S., Joachim, C. L. & Selkoe, D. J. Microtubule-associated protein tau (\u03c4) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl Acad. Sci. USA 83, 4044\u20134048 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02899034","volume":"51","author":"JM Rozemuller","year":"1986","unstructured":"Rozemuller, J. M., Eikelenboom, P. & Stam, F. C. Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study. Virchows Arch. B Cell Pathol. 51, 247\u2013254 (1986).","journal-title":"Virchows Arch. B Cell Pathol."},{"key":"BFnrn2168_CR9","first-page":"1005","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray, T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nature Med. 12, 1005\u20131015 (2006).","journal-title":"Nature Med."},{"key":"BFnrn2168_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"WR Markesbery","year":"1997","unstructured":"Markesbery, W. R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134\u2013147 (1997).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrn2168_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-2006-9S330","volume":"9","author":"PL McGeer","year":"2006","unstructured":"McGeer, P. L., Rogers, J. & McGeer, E. G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis. 9, 271\u2013276 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn2168_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/jnr.10737","volume":"74","author":"TM Allinson","year":"2003","unstructured":"Allinson, T. M., Parkin, E. T., Turner, A. J. & Hooper, N. M. ADAMs family members as amyloid precursor protein \u03b1-secretases. J. Neurosci. Res. 74, 342\u2013352 (2003).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn2168_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar, R. et al. \u03b2-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735\u2013741 (1999).","journal-title":"Science"},{"key":"BFnrn2168_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/mcne.1999.0811","volume":"14","author":"I Hussain","year":"1999","unstructured":"Hussain, I. et al. Identification of a novel aspartic protease (Asp 2) as \u03b2-secretase. Mol. Cell. Neurosci. 14, 419\u2013427 (1999).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFnrn2168_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"S Sinha","year":"1999","unstructured":"Sinha, S. et al. Purification and cloning of amyloid precursor protein \u03b2-secretase from human brain. Nature 402, 537\u2013540 (1999).","journal-title":"Nature"},{"key":"BFnrn2168_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and \u03b3-secretase activity. Nature 398, 513\u2013517 (1999).","journal-title":"Nature"},{"key":"BFnrn2168_CR17","doi-asserted-by":"publisher","first-page":"39062","DOI":"10.1074\/jbc.C200469200","volume":"277","author":"H Steiner","year":"2002","unstructured":"Steiner, H. et al. PEN-2 is an integral component of the \u03b3-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277, 39062\u201339065 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","volume":"3","author":"R Francis","year":"2002","unstructured":"Francis, R. et al. aph-1 and pen-2 are required for Notch pathway signaling, \u03b3-secretase cleavage of \u03b2APP, and presenilin protein accumulation. Dev. Cell 3, 85\u201397 (2002).","journal-title":"Dev. Cell"},{"key":"BFnrn2168_CR19","doi-asserted-by":"publisher","first-page":"12186","DOI":"10.1073\/pnas.211321898","volume":"98","author":"D Levitan","year":"2001","unstructured":"Levitan, D. et al. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc. Natl Acad. Sci. USA 98, 12186\u201312190 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/35024009","volume":"407","author":"G Yu","year":"2000","unstructured":"Yu, G. et al. Nicastrin modulates presenilin-mediated notch\/glp-1 signal transduction and \u03b2APP processing. Nature 407, 48\u201354 (2000).","journal-title":"Nature"},{"key":"BFnrn2168_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/0-387-23226-5_5","volume":"38","author":"E Kojro","year":"2005","unstructured":"Kojro, E. & Fahrenholz, F. The non-amyloidogenic pathway: structure and function of \u03b1-secretases. Subcell. Biochem. 38, 105\u2013127 (2005).","journal-title":"Subcell. Biochem."},{"key":"BFnrn2168_CR22","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/S0021-9258(18)53650-4","volume":"268","author":"C Haass","year":"1993","unstructured":"Haass, C., Hung, A. Y., Schlossmacher, M. G., Teplow, D. B. & Selkoe, D. J. \u03b2-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021\u20133024 (1993).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR23","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett, J. T., Berger, E. P. & Lansbury, P. T. Jr. The carboxy terminus of the \u03b2 amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693\u20134697 (1993).","journal-title":"Biochemistry"},{"key":"BFnrn2168_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0928-4257(98)80035-1","volume":"92","author":"SG Younkin","year":"1998","unstructured":"Younkin, S. G. The role of A\u03b2 42 in Alzheimer's disease. J. Physiol. Paris 92, 289\u2013292 (1998).","journal-title":"J. Physiol. Paris"},{"key":"BFnrn2168_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.crvi.2004.10.013","volume":"328","author":"PH St George-Hyslop","year":"2005","unstructured":"St George-Hyslop, P. H. & Petit, A. Molecular biology and genetics of Alzheimer's disease. C. R. Biol. 328, 119\u2013130 (2005).","journal-title":"C. R. Biol."},{"key":"BFnrn2168_CR26","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/nm1295-1291","volume":"1","author":"C Haass","year":"1995","unstructured":"Haass, C. et al. The Swedish mutation causes early-onset Alzheimer's disease by \u03b2-secretase cleavage within the secretory pathway. Nature Med. 1, 1291\u20131296 (1995).","journal-title":"Nature Med."},{"key":"BFnrn2168_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nn0901-887","volume":"4","author":"C Nilsberth","year":"2001","unstructured":"Nilsberth, C. et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced A\u03b2 protofibril formation. Nature Neurosci. 4, 887\u2013893 (2001).","journal-title":"Nature Neurosci."},{"key":"BFnrn2168_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/4789","volume":"5","author":"Q Guo","year":"1999","unstructured":"Guo, Q. et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nature Med. 5, 101\u2013106 (1999).","journal-title":"Nature Med."},{"key":"BFnrn2168_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky, J. L. et al. Mutant presenilins specifically elevate the levels of the 42 residue \u03b2-amyloid peptide in vivo: evidence for augmentation of a 42-specific \u03b3 secretase. Hum. Mol. Genet. 13, 159\u2013170 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrn2168_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux, A. et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nature Genet. 38, 24\u201326 (2006).","journal-title":"Nature Genet."},{"key":"BFnrn2168_CR31","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/brain\/awl237","volume":"129","author":"L Cabrejo","year":"2006","unstructured":"Cabrejo, L. et al. Phenotype associated with APP duplication in five families. Brain 129, 2966\u20132976 (2006).","journal-title":"Brain"},{"key":"BFnrn2168_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5858\/2001-125-0489-IAAPDO","volume":"125","author":"KA Gyure","year":"2001","unstructured":"Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E. & Troncoso, J. C. Intraneuronal A\u03b2-amyloid precedes development of amyloid plaques in Down syndrome. Arch. Pathol. Lab. Med. 125, 489\u2013492 (2001).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrn2168_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/13506120208995241","volume":"9","author":"C Mori","year":"2002","unstructured":"Mori, C. et al. Intraneuronal A\u03b242 accumulation in Down syndrome brain. Amyloid 9, 88\u2013102 (2002).","journal-title":"Amyloid"},{"key":"BFnrn2168_CR34","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1073\/pnas.86.8.2853","volume":"86","author":"I Grundke-Iqbal","year":"1989","unstructured":"Grundke-Iqbal, I. et al. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 2853\u20132857 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/156720506779025242","volume":"3","author":"M Blurton-Jones","year":"2006","unstructured":"Blurton-Jones, M. & Laferla, F. M. Pathways by which A\u03b2 facilitates tau pathology. Curr. Alzheimer Res. 3, 437\u2013448 (2006).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrn2168_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","volume":"156","author":"GK Gouras","year":"2000","unstructured":"Gouras, G. K. et al. Intraneuronal A\u03b242 accumulation in human brain. Am. J. Pathol. 156, 15\u201320 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrn2168_CR37","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi, R. H. et al. Intraneuronal Alzheimer A\u03b242 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 869\u20131879 (2002). Using electron microscope analysis, this paper shows that in AD brains, intraneuronal A\u03b2 accumulates within the multivesicular bodies.","journal-title":"Am. J. Pathol."},{"key":"BFnrn2168_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0304-3940(03)00252-0","volume":"342","author":"MR D'Andrea","year":"2003","unstructured":"D'Andrea, M. R. et al. The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations. Neurosci. Lett. 342, 114\u2013118 (2003).","journal-title":"Neurosci. Lett."},{"key":"BFnrn2168_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jneumeth.2006.06.010","volume":"159","author":"Y Ohyagi","year":"2007","unstructured":"Ohyagi, Y. et al. Intraneuronal amyloid \u03b242 enhanced by heating but counteracted by formic acid. J. Neurosci. Methods 159, 134\u2013138 (2007).","journal-title":"J. Neurosci. Methods"},{"key":"BFnrn2168_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/8438","volume":"5","author":"DH Chui","year":"1999","unstructured":"Chui, D. H. et al. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nature Med. 5, 560\u2013564 (1999).","journal-title":"Nature Med."},{"issue":"9","key":"BFnrn2168_CR41","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.neurobiolaging.2006.06.019","volume":"28","author":"Marlen Knobloch","year":"2007","unstructured":"Knobloch, M., Konietzko, U., Krebs, D. C. & Nitsch, R. M. Intracellular A\u03b2 and cognitive deficits precede \u03b2-amyloid deposition in transgenic arcA\u03b2 mice. Neurobiol. Aging, 31 July 2006 (doi:10.1016\/j.neurobiolaging.2006.06.019). Provides evidence linking intraneuronal A\u03b2 accumulation to cognitive deficits in transgenic mice.","journal-title":"Neurobiology of Aging"},{"key":"BFnrn2168_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF03401867","volume":"7","author":"YM Kuo","year":"2001","unstructured":"Kuo, Y. M. et al. The evolution of A\u03b2 peptide burden in the APP23 transgenic mice: implications for A\u03b2 deposition in Alzheimer disease. Mol. Med. 7, 609\u2013618 (2001).","journal-title":"Mol. Med."},{"key":"BFnrn2168_CR43","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1046\/j.1471-4159.1999.0722479.x","volume":"72","author":"QX Li","year":"1999","unstructured":"Li, Q. X. et al. Intracellular accumulation of detergent-soluble amyloidogenic A\u03b2 fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J. Neurochem. 72, 2479\u20132487 (1999).","journal-title":"J. Neurochem."},{"key":"BFnrn2168_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2004.12.007","volume":"27","author":"A Lord","year":"2006","unstructured":"Lord, A. et al. The Arctic Alzheimer mutation facilitates early intraneuronal A\u03b2 aggregation and senile plaque formation in transgenic mice. Neurobiol. Aging 27, 67\u201377 (2006).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn2168_CR45","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129\u201310140 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction. Neuron 39, 409\u2013421 (2003). Provides the earliest  in vivo  evidence that links intraneuronal A\u03b2 to synaptic dysfunction, showing that intraneuronal A\u03b2 accumulation leads to a profound LTP deficit in 3xTg-AD mice.","journal-title":"Neuron"},{"key":"BFnrn2168_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0304-3940(01)01876-6","volume":"306","author":"O Wirths","year":"2001","unstructured":"Wirths, O. et al. Intraneuronal A\u03b2 accumulation precedes plaque formation in \u03b2-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306, 116\u2013120 (2001).","journal-title":"Neurosci. Lett."},{"key":"BFnrn2168_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2353\/ajpath.2006.050593","volume":"168","author":"S Oddo","year":"2006","unstructured":"Oddo, S., Caccamo, A., Smith, I. F., Green, K. N. & LaFerla, F. M. A dynamic relationship between intracellular and extracellular pools of A\u03b2. Am. J. Pathol. 168, 184\u2013194 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnrn2168_CR49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0191-4","volume":"113","author":"J Wegiel","year":"2007","unstructured":"Wegiel, J. et al. Intraneuronal A\u03b2 immunoreactivity is not a predictor of brain amyloidosis-\u03b2 or neurofibrillary degeneration. Acta Neuropathol. (Berl) 113, 389\u2013402 (2007).","journal-title":"Acta Neuropathol. (Berl)"},{"key":"BFnrn2168_CR50","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1242\/jcs.00643","volume":"116","author":"A Kinoshita","year":"2003","unstructured":"Kinoshita, A. et al. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J. Cell Sci. 116, 3339\u20133346 (2003).","journal-title":"J. Cell Sci."},{"key":"BFnrn2168_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jnr.490280109","volume":"28","author":"KC Breen","year":"1991","unstructured":"Breen, K. C., Bruce, M. & Anderton, B. H. \u03b2 amyloid precursor protein mediates neuronal cell\u2013cell and cell\u2013surface adhesion. J. Neurosci. Res. 28, 90\u2013100 (1991).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn2168_CR52","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1083\/jcb.153.7.1403","volume":"153","author":"SL Sabo","year":"2001","unstructured":"Sabo, S. L., Ikin, A. F., Buxbaum, J. D. & Greengard, P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell Biol. 153, 1403\u20131414 (2001).","journal-title":"J. Cell Biol."},{"key":"BFnrn2168_CR53","doi-asserted-by":"publisher","first-page":"23243","DOI":"10.1074\/jbc.270.40.23243","volume":"270","author":"H Xu","year":"1995","unstructured":"Xu, H., Greengard, P. & Gandy, S. Regulated formation of Golgi secretory vesicles containing Alzheimer \u03b2-amyloid precursor protein. J. Biol. Chem. 270, 23243\u201323245 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR54","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0006-8993(92)90898-J","volume":"584","author":"M Mizuguchi","year":"1992","unstructured":"Mizuguchi, M., Ikeda, K. & Kim, S. U. Differential distribution of cellular forms of \u03b2-amyloid precursor protein in murine glial cell cultures. Brain Res. 584, 219\u2013225 (1992).","journal-title":"Brain Res."},{"key":"BFnrn2168_CR55","doi-asserted-by":"publisher","first-page":"9513","DOI":"10.1073\/pnas.90.20.9513","volume":"90","author":"AM Wertkin","year":"1993","unstructured":"Wertkin, A. M. et al. Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular \u03b2-amyloid or A4 peptides. Proc. Natl Acad. Sci. USA 90, 9513\u20139517 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR56","doi-asserted-by":"publisher","first-page":"26727","DOI":"10.1074\/jbc.270.45.26727","volume":"270","author":"BL Martin","year":"1995","unstructured":"Martin, B. L. et al. Intracellular accumulation of \u03b2-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270, 26727\u201326730 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR57","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva, E. et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genet. 39, 168\u2013177 (2007).","journal-title":"Nature Genet."},{"key":"BFnrn2168_CR58","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1126\/science.1738847","volume":"255","author":"TE Golde","year":"1992","unstructured":"Golde, T. E., Estus, S., Younkin, L. H., Selkoe, D. J. & Younkin, S. G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728\u2013730 (1992).","journal-title":"Science"},{"key":"BFnrn2168_CR59","doi-asserted-by":"publisher","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","volume":"269","author":"EH Koo","year":"1994","unstructured":"Koo, E. H. & Squazzo, S. L. Evidence that production and release of amyloid \u03b2-protein involves the endocytic pathway. J. Biol. Chem. 269, 17386\u201317389 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR60","doi-asserted-by":"publisher","first-page":"18851","DOI":"10.1074\/jbc.274.27.18851","volume":"274","author":"RG Perez","year":"1999","unstructured":"Perez, R. G. et al. Mutagenesis identifies new signals for \u03b2-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including A\u03b242. J. Biol. Chem. 274, 18851\u201318856 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR61","doi-asserted-by":"publisher","first-page":"29639","DOI":"10.1074\/jbc.M313893200","volume":"279","author":"JA Cam","year":"2004","unstructured":"Cam, J. A. et al. The low density lipoprotein receptor-related protein 1B retains \u03b2-amyloid precursor protein at the cell surface and reduces amyloid-\u03b2 peptide production. J. Biol. Chem. 279, 29639\u201329646 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR62","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1073\/pnas.90.5.2092","volume":"90","author":"J Busciglio","year":"1993","unstructured":"Busciglio, J., Gabuzda, D. H., Matsudaira, P. & Yankner, B. A. Generation of \u03b2-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 2092\u20132096 (1993). Provides strong evidence that A\u03b2 in neurons is generated by the secretory pathway.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR63","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/nm0997-1021","volume":"3","author":"DG Cook","year":"1997","unstructured":"Cook, D. G. et al. Alzheimer's A \u03b2(1\u201342) is generated in the endoplasmic reticulum\/intermediate compartment of NT2N cells. Nature Med. 3, 1021\u20131023 (1997).","journal-title":"Nature Med."},{"key":"BFnrn2168_CR64","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0698-730","volume":"4","author":"SJ Lee","year":"1998","unstructured":"Lee, S. J. et al. A detergent-insoluble membrane compartment contains A \u03b2 in vivo. Nature Med. 4, 730\u2013734 (1998).","journal-title":"Nature Med."},{"key":"BFnrn2168_CR65","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1083\/jcb.141.4.1031","volume":"141","author":"DM Skovronsky","year":"1998","unstructured":"Skovronsky, D. M., Doms, R. W. & Lee, V. M. Detection of a novel intraneuronal pool of insoluble amyloid \u03b2 protein that accumulates with time in culture. J. Cell Biol. 141, 1031\u20131039 (1998).","journal-title":"J. Cell Biol."},{"key":"BFnrn2168_CR66","doi-asserted-by":"publisher","first-page":"16085","DOI":"10.1074\/jbc.272.26.16085","volume":"272","author":"C Wild-Bode","year":"1997","unstructured":"Wild-Bode, C. et al. Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16085\u201316088 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR67","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm0997-1016","volume":"3","author":"T Hartmann","year":"1997","unstructured":"Hartmann, T. et al. Distinct sites of intracellular production for Alzheimer's disease A \u03b240\/42 amyloid peptides. Nature Med. 3, 1016\u201310120 (1997). Shows that both A\u03b2 40  and A\u03b2 42  are generated intracellularly but at different sites.","journal-title":"Nature Med."},{"key":"BFnrn2168_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1196\/annals.1377.005","volume":"1086","author":"G Bu","year":"2006","unstructured":"Bu, G., Cam, J. & Zerbinatti, C. LRP in amyloid-\u03b2 production and metabolism. Ann. N. Y. Acad. Sci. 1086, 35\u201353 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFnrn2168_CR69","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nm890","volume":"9","author":"R Deane","year":"2003","unstructured":"Deane, R. et al. RAGE mediates amyloid-\u03b2 peptide transport across the blood\u2013brain barrier and accumulation in brain. Nature Med. 9, 907\u2013913 (2003).","journal-title":"Nature Med."},{"key":"BFnrn2168_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","volume":"110","author":"RG Nagele","year":"2002","unstructured":"Nagele, R. G., D'Andrea, M. R., Anderson, W. J. & Wang, H. Y. Intracellular accumulation of \u03b2-amyloid1\u201342 in neurons is facilitated by the \u03b17 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199\u2013211 (2002). Shows that A\u03b2 binds to \u03b17nAChR and suggests that it is subsequently internalized, thus providing a mechanism for intraneuronal A\u03b2 accumulation.","journal-title":"Neuroscience"},{"key":"BFnrn2168_CR71","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1096\/fj.01-0251com","volume":"15","author":"H Yazawa","year":"2001","unstructured":"Yazawa, H. et al. \u03b2 amyloid peptide (A\u03b242) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15, 2454\u20132462 (2001).","journal-title":"FASEB J."},{"key":"BFnrn2168_CR72","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.brainres.2007.01.070","volume":"1142","author":"PM Clifford","year":"2007","unstructured":"Clifford, P. M. et al. A\u03b2 peptides can enter the brain through a defective blood\u2013brain barrier and bind selectively to neurons. Brain Res. 1142, 223\u2013236 (2007).","journal-title":"Brain Res."},{"key":"BFnrn2168_CR73","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1074\/jbc.275.8.5626","volume":"275","author":"HY Wang","year":"2000","unstructured":"Wang, H. Y. et al. \u03b2-Amyloid1\u201342 binds to \u03b17 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275, 5626\u20135632 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR74","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1073\/pnas.0408500102","volume":"102","author":"S Oddo","year":"2005","unstructured":"Oddo, S. et al. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 102, 3046\u20133051 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR75","doi-asserted-by":"publisher","first-page":"36180","DOI":"10.1074\/jbc.M604436200","volume":"281","author":"CV Zerbinatti","year":"2006","unstructured":"Zerbinatti, C. V. et al. Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal A\u03b242 accumulation in amyloid model mice. J. Biol. Chem. 281, 36180\u201336186 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/382685a0","volume":"382","author":"SD Yan","year":"1996","unstructured":"Yan, S. D. et al. RAGE and amyloid-\u03b2 peptide neurotoxicity in Alzheimer's disease. Nature 382, 685\u2013691 (1996).","journal-title":"Nature"},{"key":"BFnrn2168_CR77","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0006-8993(00)03075-4","volume":"888","author":"N Sasaki","year":"2001","unstructured":"Sasaki, N. et al. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res. 888, 256\u2013262 (2001).","journal-title":"Brain Res."},{"key":"BFnrn2168_CR78","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1073\/pnas.94.10.5296","volume":"94","author":"S Du Yan","year":"1997","unstructured":"Du Yan, S. et al. Amyloid-\u03b2 peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl Acad. Sci. USA 94, 5296\u20135301 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR79","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1385\/IR:31:3:165","volume":"31","author":"P Iribarren","year":"2005","unstructured":"Iribarren, P., Zhou, Y., Hu, J., Le, Y. & Wang, J. M. Role of formyl peptide receptor-like 1 (FPRL1\/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol. Res. 31, 165\u2013176 (2005).","journal-title":"Immunol. Res."},{"key":"BFnrn2168_CR80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nn1503","volume":"8","author":"EM Snyder","year":"2005","unstructured":"Snyder, E. M. et al. Regulation of NMDA receptor trafficking by amyloid-\u03b2. Nature Neurosci. 8, 1051\u20131058 (2005).","journal-title":"Nature Neurosci."},{"key":"BFnrn2168_CR81","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0306-4522(02)00132-X","volume":"112","author":"X Bi","year":"2002","unstructured":"Bi, X., Gall, C. M., Zhou, J. & Lynch, G. Uptake and pathogenic effects of amyloid \u03b2 peptide 1\u201342 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists. Neuroscience 112, 827\u2013840 (2002).","journal-title":"Neuroscience"},{"key":"BFnrn2168_CR82","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg, B. et al. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 348, 1333\u20131341 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrn2168_CR83","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1124\/jpet.104.071027","volume":"311","author":"R Minkeviciene","year":"2004","unstructured":"Minkeviciene, R., Banerjee, P. & Tanila, H. Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J. Pharmacol. Exp. Ther. 311, 677\u2013682 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrn2168_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nn1372","volume":"8","author":"JP Cleary","year":"2005","unstructured":"Cleary, J. P. et al. Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function. Nature Neurosci. 8, 79\u201384 (2005).","journal-title":"Nature Neurosci."},{"key":"BFnrn2168_CR85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M. et al. Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002).","journal-title":"Nature"},{"key":"BFnrn2168_CR86","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne, S. et al. A specific amyloid-\u03b2 protein assembly in the brain impairs memory. Nature 440, 352\u2013357 (2006).","journal-title":"Nature"},{"key":"BFnrn2168_CR87","doi-asserted-by":"publisher","first-page":"10831","DOI":"10.1021\/bi001048s","volume":"39","author":"DM Walsh","year":"2000","unstructured":"Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B. & Selkoe, D. J. The oligomerization of amyloid \u03b2-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10831\u201310839 (2000). Using cells from the human brain, this paper shows that A\u03b2 oligomerization starts intraneuronally.","journal-title":"Biochemistry"},{"key":"BFnrn2168_CR88","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1074\/jbc.M507892200","volume":"281","author":"S Oddo","year":"2006","unstructured":"Oddo, S. et al. Temporal profile of amyloid-\u03b2 (A\u03b2) oligomerization in an in vivo model of Alzheimer disease. A link between A\u03b2 and tau pathology. J. Biol. Chem. 281, 1599\u20131604 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR89","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","volume":"24","author":"RH Takahashi","year":"2004","unstructured":"Takahashi, R. H. et al. Oligomerization of Alzheimer's \u03b2-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 3592\u20133599 (2004). Shows that A\u03b2 oligomers accumulate intraneuronally in AD brain.","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR90","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/jcb.20978","volume":"99","author":"SI Kim","year":"2006","unstructured":"Kim, S. I., Yi, J. S. & Ko, Y. G. Amyloid \u03b2 oligomerization is induced by brain lipid rafts. J. Cell Biochem. 99, 878\u2013889 (2006).","journal-title":"J. Cell Biochem."},{"key":"BFnrn2168_CR91","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","volume":"24","author":"T Kawarabayashi","year":"2004","unstructured":"Kawarabayashi, T. et al. Dimeric amyloid \u03b2 protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 24, 3801\u20133809 (2004).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR92","doi-asserted-by":"publisher","first-page":"33561","DOI":"10.1074\/jbc.M103598200","volume":"276","author":"SA Waschuk","year":"2001","unstructured":"Waschuk, S. A., Elton, E. A., Darabie, A. A., Fraser, P. E. & McLaurin, J. A. Cellular membrane composition defines A\u03b2-lipid interactions. J. Biol. Chem. 276, 33561\u201333568 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR93","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbamem.2006.09.014","volume":"1768","author":"K Matsuzaki","year":"2007","unstructured":"Matsuzaki, K. et al. Inhibitors of amyloid \u03b2-protein aggregation mediated by GM1-containing raft-like membranes. Biochim. Biophys. Acta 1768, 122\u2013130 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrn2168_CR94","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.bbrc.2005.01.060","volume":"328","author":"M Wakabayashi","year":"2005","unstructured":"Wakabayashi, M., Okada, T., Kozutsumi, Y. & Matsuzaki, K. GM1 ganglioside-mediated accumulation of amyloid \u03b2-protein on cell membranes. Biochem. Biophys. Res. Commun. 328, 1019\u20131023 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrn2168_CR95","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.febslet.2004.05.037","volume":"569","author":"N Yamamoto","year":"2004","unstructured":"Yamamoto, N. et al. Accelerated A\u03b2 aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett. 569, 135\u2013139 (2004).","journal-title":"FEBS Lett."},{"key":"BFnrn2168_CR96","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1365-2559.2001.01082.x","volume":"38","author":"MR D'Andrea","year":"2001","unstructured":"D'Andrea, M. R., Nagele, R. G., Wang, H. Y., Peterson, P. A. & Lee, D. H. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120\u2013134 (2001). Provides evidence suggesting that in the brains of patients with AD, intracellular A\u03b2 accumulation may lead to neuronal death, and that after being released in the extracellular compartment, it can contribute to the formation of plaques.","journal-title":"Histopathology"},{"key":"BFnrn2168_CR97","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/(SICI)1096-9861(19980720)397:1<139::AID-CNE10>3.0.CO;2-K","volume":"397","author":"BA Bahr","year":"1998","unstructured":"Bahr, B. A. et al. Amyloid \u03b2 protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397, 139\u2013147 (1998).","journal-title":"J. Comp. Neurol."},{"key":"BFnrn2168_CR98","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk, D. et al. Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173\u2013177 (1999).","journal-title":"Nature"},{"key":"BFnrn2168_CR99","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus, C. et al. A\u03b2 peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979\u2013982 (2000).","journal-title":"Nature"},{"key":"BFnrn2168_CR100","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H. & LaFerla, F. M. A\u03b2 immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321\u2013332 (2004). Shows that A\u03b2 immunotherapy clears intraneuronal A\u03b2 accumulation, which leads to the removal of tau deposits, thus linking intracellular A\u03b2 and tau pathology.","journal-title":"Neuron"},{"key":"BFnrn2168_CR101","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neurobiolaging.2005.05.022","volume":"26","author":"GK Gouras","year":"2005","unstructured":"Gouras, G. K., Almeida, C. G. & Takahashi, R. H. Intraneuronal A\u03b2 accumulation and origin of plaques in Alzheimer's disease. Neurobiol. Aging 26, 1235\u20131244 (2005).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn2168_CR102","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2174\/1567205043332045","volume":"1","author":"BP Tseng","year":"2004","unstructured":"Tseng, B. P., Kitazawa, M. & LaFerla, F. M. Amyloid \u03b2-peptide: the inside story. Curr. Alzheimer Res. 1, 231\u2013239 (2004).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrn2168_CR103","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0002-9440(10)63405-0","volume":"165","author":"D Langui","year":"2004","unstructured":"Langui, D. et al. Subcellular topography of neuronal A\u03b2 peptide in APPxPS1 transgenic mice. Am. J. Pathol. 165, 1465\u20131477 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrn2168_CR104","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1523\/JNEUROSCI.5078-05.2006","volume":"26","author":"CG Almeida","year":"2006","unstructured":"Almeida, C. G., Takahashi, R. H. & Gouras, G. K. \u03b2-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin\u2013proteasome system. J. Neurosci. 26, 4277\u20134288 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR105","doi-asserted-by":"publisher","first-page":"19702","DOI":"10.1074\/jbc.270.34.19702","volume":"270","author":"L Gregori","year":"1995","unstructured":"Gregori, L., Fuchs, C., Figueiredo-Pereira, M. E., Van Nostrand, W. E. & Goldgaber, D. Amyloid \u03b2-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem. 270, 19702\u201319708 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR106","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.mad.2005.07.006","volume":"126","author":"S Oh","year":"2005","unstructured":"Oh, S. et al. Amyloid peptide attenuates the proteasome activity in neuronal cells. Mech. Ageing Dev. 126, 1292\u20131299 (2005).","journal-title":"Mech. Ageing Dev."},{"key":"BFnrn2168_CR107","unstructured":"Tseng, B. P., Green, K. N., Chan, J., Blurton-Jones, M. & LaFerla, F. A\u03b2 inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging (in the press)."},{"key":"BFnrn2168_CR108","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","volume":"15","author":"M Manczak","year":"2006","unstructured":"Manczak, M. et al. Mitochondria are a direct site of A\u03b2 accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15, 1437\u20131449 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrn2168_CR109","doi-asserted-by":"publisher","first-page":"51654","DOI":"10.1074\/jbc.M404500200","volume":"279","author":"CA Hansson","year":"2004","unstructured":"Hansson, C. A. et al. Nicastrin, presenilin, APH-1, and PEN-2 form active \u03b3-secretase complexes in mitochondria. J. Biol. Chem. 279, 51654\u201351660 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrn2168_CR110","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1096\/fj.05-3735fje","volume":"19","author":"C Caspersen","year":"2005","unstructured":"Caspersen, C. et al. Mitochondrial A\u03b2: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 19, 2040\u20132041 (2005).","journal-title":"FASEB J."},{"key":"BFnrn2168_CR111","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-2006-9206","volume":"9","author":"U Keil","year":"2006","unstructured":"Keil, U. et al. Mitochondrial dysfunction induced by disease relevant A\u03b2PP and tau protein mutations. J. Alzheimers Dis. 9, 139\u2013146 (2006).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrn2168_CR112","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L. & LaFerla, F. M. Intraneuronal A\u03b2 causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675\u2013688 (2005). Shows that intraneuronal A\u03b2 accumulation is responsible for the onset of cognitive decline in the 3xTg-AD.","journal-title":"Neuron"},{"key":"BFnrn2168_CR113","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/319774a0","volume":"319","author":"RG Morris","year":"1986","unstructured":"Morris, R. G., Anderson, E., Lynch, G. S. & Baudry, M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774\u2013776 (1986).","journal-title":"Nature"},{"key":"BFnrn2168_CR114","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2006.06.046","volume":"126","author":"B Gong","year":"2006","unstructured":"Gong, B. et al. Ubiquitin hydrolase Uch-L1 rescues \u03b2-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775\u2013788 (2006).","journal-title":"Cell"},{"key":"BFnrn2168_CR115","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","volume":"27","author":"KN Green","year":"2007","unstructured":"Green, K. N. et al. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-\u03b2 and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27, 4385\u20134395 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR116","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/jn\/135.3.549","volume":"135","author":"M Hashimoto","year":"2005","unstructured":"Hashimoto, M. et al. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid \u03b2-infused rats. J. Nutr. 135, 549\u2013555 (2005).","journal-title":"J. Nutr."},{"key":"BFnrn2168_CR117","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","volume":"25","author":"GP Lim","year":"2005","unstructured":"Lim, G. P. et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25, 3032\u20133040 (2005).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR118","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","volume":"21","author":"L Gasparini","year":"2001","unstructured":"Gasparini, L. et al. Stimulation of \u03b2-amyloid precursor protein trafficking by insulin reduces intraneuronal \u03b2-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21, 2561\u20132570 (2001).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR119","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1523\/JNEUROSCI.4800-06.2007","volume":"27","author":"LM Billings","year":"2007","unstructured":"Billings, L. M., Green, K. N., McGaugh, J. L. & LaFerla, F. M. Learning decreases A\u03b2*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice. J. Neurosci. 27, 751\u2013761 (2007).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR120","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","volume":"26","author":"KN Green","year":"2006","unstructured":"Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L. & LaFerla, F. M. Glucocorticoids increase amyloid-\u03b2 and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26, 9047\u20139056 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR121","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/exnr.1994.1044","volume":"126","author":"DL Sparks","year":"1994","unstructured":"Sparks, D. L. et al. Induction of Alzheimer-like \u03b2-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126, 88\u201394 (1994).","journal-title":"Exp. Neurol."},{"key":"BFnrn2168_CR122","doi-asserted-by":"publisher","first-page":"6951","DOI":"10.1021\/bi000169p","volume":"39","author":"H Misonou","year":"2000","unstructured":"Misonou, H., Morishima-Kawashima, M. & Ihara, Y. Oxidative stress induces intracellular accumulation of amyloid \u03b2-protein (A\u03b2) in human neuroblastoma cells. Biochemistry 39, 6951\u20136959 (2000).","journal-title":"Biochemistry"},{"key":"BFnrn2168_CR123","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jnr.20514","volume":"80","author":"T Hasegawa","year":"2005","unstructured":"Hasegawa, T. et al. Homocysteic acid induces intraneuronal accumulation of neurotoxic A\u03b242: implications for the pathogenesis of Alzheimer's disease. J. Neurosci. Res. 80, 869\u2013876 (2005).","journal-title":"J. Neurosci. Res."},{"key":"BFnrn2168_CR124","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3940(02)00875-3","volume":"333","author":"MR D'Andrea","year":"2002","unstructured":"D'Andrea, M. R., Nagele, R. G., Wang, H. Y. & Lee, D. H. Consistent immunohistochemical detection of intracellular \u03b2-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. Neurosci. Lett. 333, 163\u2013166 (2002).","journal-title":"Neurosci. Lett."},{"key":"BFnrn2168_CR125","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0304-3940(01)02444-2","volume":"323","author":"MR D'Andrea","year":"2002","unstructured":"D'Andrea, M. R. et al. Lipofuscin and A\u03b242 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci. Lett. 323, 45\u201349 (2002).","journal-title":"Neurosci. Lett."},{"key":"BFnrn2168_CR126","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1172\/JCI119536","volume":"100","author":"FM LaFerla","year":"1997","unstructured":"LaFerla, F. M., Troncoso, J. C., Strickland, D. K., Kawas, C. H. & Jay, G. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular A\u03b2 stabilization. J. Clin. Invest. 100, 310\u2013320 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrn2168_CR127","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0140-6736(99)04937-5","volume":"355","author":"A Mochizuki","year":"2000","unstructured":"Mochizuki, A., Tamaoka, A., Shimohata, A., Komatsuzaki, Y. & Shoji, S. A\u03b242-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355, 42\u201343 (2000).","journal-title":"Lancet"},{"key":"BFnrn2168_CR128","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archneur.1991.00530240033013","volume":"48","author":"JR Mendell","year":"1991","unstructured":"Mendell, J. R., Sahenk, Z., Gales, T. & Paul, L. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments. Arch. Neurol. 48, 1229\u20131234 (1991).","journal-title":"Arch. Neurol."},{"key":"BFnrn2168_CR129","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00001756-199306000-00055","volume":"4","author":"E Sarkozi","year":"1993","unstructured":"Sarkozi, E., Askanas, V., Johnson, S. A., Engel, W. K. & Alvarez, R. B. \u03b2-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport 4, 815\u2013818 (1993).","journal-title":"Neuroreport"},{"key":"BFnrn2168_CR130","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1212\/WNL.43.6.1265-a","volume":"43","author":"V Askanas","year":"1993","unstructured":"Askanas, V., Engel, W. K. & Alvarez, R. B. Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurology 43, 1265\u20131267 (1993).","journal-title":"Neurology"},{"key":"BFnrn2168_CR131","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2990.2004.00624.x","volume":"31","author":"N Kimura","year":"2005","unstructured":"Kimura, N. et al. Age-related changes of intracellular A\u03b2 in cynomolgus monkey brains. Neuropathol. Appl. Neurobiol. 31, 170\u2013180 (2005).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrn2168_CR132","first-page":"1358","volume":"145","author":"LJ Martin","year":"1994","unstructured":"Martin, L. J., Pardo, C. A., Cork, L. C. & Price, D. L. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am. J. Pathol. 145, 1358\u20131381 (1994).","journal-title":"Am. J. Pathol."},{"key":"BFnrn2168_CR133","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0197-4580(93)90038-D","volume":"14","author":"BJ Cummings","year":"1993","unstructured":"Cummings, B. J., Su, J. H., Cotman, C. W., White, R. & Russell, M. J. \u03b2-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol. Aging 14, 547\u2013560 (1993).","journal-title":"Neurobiol. Aging"},{"key":"BFnrn2168_CR134","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0306-4522(99)00568-0","volume":"96","author":"R Torp","year":"2000","unstructured":"Torp, R. et al. Ultrastructural evidence of fibrillar \u03b2-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience 96, 495\u2013506 (2000).","journal-title":"Neuroscience"},{"key":"BFnrn2168_CR135","doi-asserted-by":"publisher","first-page":"10536","DOI":"10.1523\/JNEUROSCI.3133-06.2006","volume":"26","author":"JC Cruz","year":"2006","unstructured":"Cruz, J. C. et al. p25\/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid \u03b2 in vivo. J. Neurosci. 26, 10536\u201310541 (2006).","journal-title":"J. Neurosci."},{"key":"BFnrn2168_CR136","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0002-9440(10)63388-3","volume":"165","author":"C Casas","year":"2004","unstructured":"Casas, C. et al. Massive CA1\/2 neuronal loss with intraneuronal and N-terminal truncated A\u03b242 accumulation in a novel Alzheimer transgenic model. Am. J. Pathol. 165, 1289\u20131300 (2004). Provides  in vivo  evidence that intraneuronal A\u03b2 accumulation is toxic and leads to cell death.","journal-title":"Am. J. Pathol."},{"issue":"2","key":"BFnrn2168_CR137","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neurobiolaging.2006.10.016","volume":"29","author":"Bianca Van Broeck","year":"2008","unstructured":"Van Broeck, B. et al. Intraneuronal amyloid \u03b2 and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol. Aging 16 Nov 2006 (doi:10.1016\/j.neurobiolaging.2006.10.016).","journal-title":"Neurobiology of Aging"},{"key":"BFnrn2168_CR138","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00001756-200301200-00023","volume":"14","author":"FS Shie","year":"2003","unstructured":"Shie, F. S., LeBoeuf, R. C. & Jin, L. W. Early intraneuronal A\u03b2 deposition in the hippocampus of APP transgenic mice. Neuroreport 14, 123\u2013129 (2003).","journal-title":"Neuroreport"},{"key":"BFnrn2168_CR139","doi-asserted-by":"publisher","first-page":"10960","DOI":"10.1523\/JNEUROSCI.1723-05.2005","volume":"25","author":"J Magrane","year":"2005","unstructured":"Magrane, J. et al. Intraneuronal \u03b2-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J. Neurosci. 25, 10960\u201310969 (2005).","journal-title":"J. Neurosci."},{"issue":"12","key":"BFnrn2168_CR140","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1016\/j.neurobiolaging.2006.08.013","volume":"28","author":"Zhiming Suo","year":"2007","unstructured":"Suo, Z. et al. GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment. Neurobiol. Aging 2 October 2006 (doi: 10.1016\/j.neurobiolaging.2006.08.013).","journal-title":"Neurobiology of Aging"},{"key":"BFnrn2168_CR141","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1073\/pnas.082545599","volume":"99","author":"MC Sugarman","year":"2002","unstructured":"Sugarman, M. C. et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of \u03b2APP in skeletal muscle. Proc. Natl Acad. Sci. USA 99, 6334\u20136339 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrn2168_CR142","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.2353\/ajpath.2006.051232","volume":"168","author":"M Kitazawa","year":"2006","unstructured":"Kitazawa, M., Green, K. N., Caccamo, A. & LaFerla, F. M. Genetically augmenting A\u03b242 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am. J. Pathol. 168, 1986\u20131997 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnrn2168_CR143","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1096\/fj.06-5763fje","volume":"20","author":"CE Moussa","year":"2006","unstructured":"Moussa, C. E. et al. Transgenic expression of \u03b2-APP in fast-twitch skeletal muscle leads to calcium dyshomeostasis and IBM-like pathology. FASEB J. 20, 2165\u20132167 (2006).","journal-title":"FASEB J."},{"key":"BFnrn2168_CR144","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuroscience.2004.07.036","volume":"129","author":"V Echeverria","year":"2004","unstructured":"Echeverria, V. et al. Altered mitogen-activated protein kinase signaling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing the \u03b2-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience 129, 583\u2013592 (2004).","journal-title":"Neuroscience"},{"key":"BFnrn2168_CR145","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/00002281-200211000-00004","volume":"14","author":"R Tawil","year":"2002","unstructured":"Tawil, R. & Griggs, R. C. Inclusion body myositis. Curr. Opin. Rheumatol. 14, 653\u2013657 (2002).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrn2168_CR146","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1212\/01.wnl.0000192128.13875.1e","volume":"66","author":"V Askanas","year":"2006","unstructured":"Askanas, V. & Engel, W. K. Inclusion-body myositis: a myodegenerative conformational disorder associated with A\u03b2, protein misfolding, and proteasome inhibition. Neurology 66, S39\u2013S48 (2006).","journal-title":"Neurology"}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrn2168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrn2168","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrn2168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:25:00Z","timestamp":1650101100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrn2168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":146,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BFnrn2168"],"URL":"https:\/\/doi.org\/10.1038\/nrn2168","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}